Control of ethanol utilization by rat hepatocytes.

Biochim Biophys Acta

Published: August 1981

Ethanol oxidation by hepatocytes from fasted rats was determined in the presence and absence of 0.2 mM ethyl hydrazinoacetate, a transaminase inhibitor which blocks the malate-aspartate cycle. 20 muM phenazine methosulfate caused the largest increase (nearly 150%) in ethanol utilization. 5 muM norepinephrine caused a 50% increase in ethanol oxidation, and most of this increase was caused by stimulation of the alpha-glycerophosphate shuttle, since it remained in the presence of ethyl hydrazinoacetate. 1 muM glucagon caused a 25% increase in ethanol uptake, and most of this increase was abolished by ethyl hydrazinoacetate, indicating that the malate-aspartate cycle was involved. 25 muM dinitrophenol increased ethanol use by 20% and this increase was nearly unaffected by ethyl hydrazinoacetate. The results indicate that ethanol utilization, under the conditions used, is primarily controlled by the capacity of the shuttle systems, and not by the capacity of the respiratory chain.

Download full-text PDF

Source
http://dx.doi.org/10.1016/0304-4165(81)90196-3DOI Listing

Publication Analysis

Top Keywords

ethyl hydrazinoacetate
16
ethanol utilization
12
ethanol oxidation
8
malate-aspartate cycle
8
increase ethanol
8
ethanol
6
increase
6
control ethanol
4
utilization rat
4
rat hepatocytes
4

Similar Publications

Novel Pd(II) complex with N-heteroaromatic Schiff base ligand, derived from 8-quinolinecarboxaldehyde (q8a) and ethyl hydrazinoacetate (haOEt), was synthesized and characterized by analytical and spectroscopy methods. The structure of novel complex, as well as structures of its quinoline and pyridine analogues, was optimized by density functional theory calculations, and theoretical data show good agreement with experimental results. A cytotoxic action of the complexes was evaluated on cultures of human promyelocytic leukemia (HL-60), human glioma (U251), rat glioma (C6), and mouse fibrosarcoma (L929) cell lines.

View Article and Find Full Text PDF

A new palladium(II) complex 1 of the condensation product of 2-(diphenylphosphino)benzaldehyde (dpba) and ethyl hydrazinoacetate (etha) was synthesized and characterized by elemental analyses, IR, and (1)H NMR spectroscopy. The bound ligand is a bidentate (PN chromophore), the remaining two coordination places being occupied by chloride ions in overall square planar geometry. The cytotoxic activity of the complex 1 and two related Pd(II) and Pt(II) complexes 2 and 3 was tested against a panel of four tumor cell lines.

View Article and Find Full Text PDF

The inhibitory activities of hydrazinoacetic acid (HAA), 2-hydrazinoethanol (HE) and ethyl hydrazino-acetate (EHA) are characterized and compared with those of L-or D-alpha-hydrazino-beta-phenylpropionic acid (L-or D-HPPA), 2-phenylethylhydrazine (PEH), hydrazine (H), alpha, beta-dihydrocinnamic acid (DHCA) and D-phenylalanine (D-Phe). Inhibitors can be arranged in order of increasing activity: HE less than EHA less than H less than D-Phe less than HAA less than D-HPPA less than DHCA less than PEH less than L-HPPA. Relations between activity and structure of inhibitors are discussed.

View Article and Find Full Text PDF

Ethanol oxidation by hepatocytes from fasted rats was determined in the presence and absence of 0.2 mM ethyl hydrazinoacetate, a transaminase inhibitor which blocks the malate-aspartate cycle. 20 muM phenazine methosulfate caused the largest increase (nearly 150%) in ethanol utilization.

View Article and Find Full Text PDF

Both ethyl hydrazinoacetate and aminooxyacetate strongly inhibit gluconeogenesis from L-lactate, but not from pyruvate or fructose, in rat hepatocytes. Ethyl hydrazinoacetate partially inhibits gluconeogenesis from polyols, and also partially inhibits ethanol oxidation. In contrast to results obtained with aminooxyacetate, increasing the ethyl hydrazinoacetate concentration from 0.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!